Peptides for Testosterone: Which Ones Actually Raise It

There is a category error at the center of this topic, and clearing it up settles most of the question.

The peptides sold hardest to men who want more testosterone — sermorelin, ipamorelin, CJC-1295, the GHRPs — act on the growth hormone axis. They ask the pituitary to release growth hormone. Growth hormone and testosterone are different hormones, released by different mechanisms, doing different things. A growth-hormone secretagogue is not a testosterone product, and it is not marketed as one so much as sold next to one.

The peptides that genuinely move testosterone are a much smaller group, and they all work the same way: by acting on the luteinizing hormone signal that tells the testes to produce it. That group is kisspeptin, gonadorelin (a GnRH analog), and hCG. Those have real human data, and it is worth knowing what it does and does not show.

How the Axis Works, Briefly

The chain runs in one direction. The hypothalamus releases GnRH, which tells the pituitary to release luteinizing hormone, which tells the testes to make testosterone. Kisspeptin sits upstream of GnRH and is one of its key drivers.

Anything that raises testosterone through this route is working with your own production rather than replacing it — which is the entire appeal, because exogenous testosterone shuts the chain down from the top.

Everything else in the peptide catalog either enters the chain somewhere real or does not touch it at all. The GH secretagogues do not.

Kisspeptin — the One With New Controlled Data

Kisspeptin is the most interesting compound here because the human work is recent and it is properly designed.

A randomized study found that chronic subcutaneous kisspeptin-10 stimulated gonadotropin secretion for 12 days in healthy men¹ — a sustained effect, which matters because a compound that works acutely and then stops being effective is a different proposition from one that holds. Separate work has examined how continuous kisspeptin infusion dynamically modulates LH secretion², and how the reproductive axis's responsiveness to kisspeptin-10 changes with age³.

There is also evidence in a population with an actual problem: in men with type 2 diabetes and mild biochemical hypogonadism, kisspeptin-10 stimulated serum testosterone and LH secretion⁴. That is the shape of a real finding — a defined population, a measured hormone, a controlled administration.

The mechanism is further confirmed from the other direction, which is the sort of evidence that makes a pathway credible. Blocking the neighboring neurokinin-3 receptor decreased gonadotropin and testosterone secretion in healthy men⁵. Push the system and testosterone goes up; block it and testosterone goes down. That is a pathway doing what a pathway should.

What none of this establishes is the thing a buyer wants: that injecting kisspeptin makes a healthy man with normal testosterone feel better, perform better, or gain muscle. The studies measured hormones, not outcomes. Our full assessment is in kisspeptin.

hCG and Gonadorelin — the Clinically Established Route

hCG mimics luteinizing hormone directly, signaling the testes without going through the pituitary at all. It is the most established compound in this group and the one with an actual clinical role.

The role that matters most: exogenous testosterone suppresses the body's own signal and with it sperm production — the expected consequence rather than a rare side effect, as the review literature on testosterone replacement and spermatogenesis sets out⁶. Concomitant intramuscular hCG preserved spermatogenesis in men undergoing testosterone replacement therapy⁷. That is a specific, clinically actionable result and it is why hCG appears beside TRT rather than beside the research peptides.

Gonadorelin is a GnRH analog acting one step higher in the chain, and it shows up on the same menus for the same reason. LaSara prices gonadorelin at $99 either way — one time or subscribed — alongside TRT at $169 a month, on product pages that publish a one-time price, a subscription price and a per-day cost for everything.

We cover the compound in depth, including the claim of its that failed, in hCG: real approvals and one dead claim.

What the GH Peptides Actually Do

To be fair to them: sermorelin, ipamorelin and CJC-1295 are not frauds. They do something — they raise growth hormone and IGF-1. The problem is only that this is a different hormone from the one you came for.

And the outcome evidence on that axis is weak on its own terms. A systematic review of growth hormone in healthy, athletic participants found increased lean body mass that the reviewers attributed largely to fluid retention, with no improvement in strength or exercise capacity and more adverse events⁸. So the GH route is neither a testosterone product nor a well-evidenced performance one.

If low testosterone is the actual issue, the honest options are a diagnosis and monitored treatment, not a peptide bought on a related-sounding mechanism. We cover the compounds in GH peptides and recovery and CJC-1295 and ipamorelin, the category confusion in are peptides steroids, and what monitored treatment costs on best online TRT providers.

Worth noting how these products are actually sold: Hone Health's sermorelin page shows "$130/mo" when the real figure is $285 because the product requires a $155 membership, and fourteen states plus D.C. cannot buy it. ElitePhysiqMD prices sermorelin at $267.30 a month on a page advertising the category "from $161/mo". RxSpan MD publishes a genuine $179 month-to-month rate, which is what a straightforward version looks like.

What About Enclomiphene and the Other "Restart" Products?

Worth naming, because these sell alongside the peptides and get grouped with them, and two of the three are not peptides at all.

Enclomiphene and clomiphene are selective estrogen receptor modulators — small molecules, not peptides. They raise testosterone by blocking estrogen feedback at the pituitary, which is a fourth entry point into the same axis. Whatever their merits, they belong in a different chemical category from anything else on this page.

Gonadorelin is a genuine peptide and a genuine GnRH analog, which is why it appears on the axis diagram above.

The practical point is that "peptide" is doing no work in the marketing here. What determines whether something raises testosterone is where it enters the hypothalamic-pituitary-gonadal chain, not what class of molecule it belongs to — the same lesson as is Ozempic a peptide, where the chemical class turned out to carry no information about whether something works.

What "Optimizing" Testosterone Actually Requires

One more thing the product pages skip, and it is the part that decides whether any of this is a good idea.

Testosterone is a number you can measure, and measurement is what separates treatment from guessing. That means a baseline drawn correctly — testosterone is diurnal, so morning timing matters — repeated to confirm, with the pituitary hormones measured alongside it to establish whether a low reading comes from the testes or from the signal above them. That distinction is the whole diagnosis, and it determines which of the compounds on this page could even be relevant.

A vial bought on the strength of feeling tired skips every step of that. And if the reading is genuinely low, the follow-on questions — fertility, hematocrit, monitoring interval — are the sort a prescriber manages rather than a protocol. See best online TRT providers for what the monitored version involves and costs, and are peptides bad for you for the risk framing across the category.

The Anti-Doping Position

Unambiguous and worth stating, because this group is prohibited on both sides. hCG is prohibited for male athletes under the World Anti-Doping Code, and its use alongside androgens is precisely why. The GH secretagogues are prohibited in their own class. A restart or fertility rationale is not an exemption. Check any compound with our WADA prohibited-status checker and see the 2026 Prohibited List for peptides.

Bottom Line

Sort the category first and most of the confusion goes away.

Peptides that act on the testosterone axis: kisspeptin, gonadorelin, hCG. These have genuine human data — kisspeptin-10 sustained gonadotropin stimulation over 12 days in healthy men¹ and raised testosterone in men with mild hypogonadism⁴, and the pathway confirms from both directions⁵. hCG preserved spermatogenesis alongside TRT⁷, which is the most clinically useful result in the group.

Peptides that do not: the GH secretagogues, which act on a different hormone entirely and whose own outcome evidence shows lean-mass gain that is largely fluid with no strength benefit⁸.

What none of them has shown: that a healthy man with normal testosterone gets a meaningful benefit. The studies measured hormones. Feeling better, performing better and gaining muscle are different endpoints, and they were not the ones tested.

If testosterone is genuinely low, that is a diagnosis with monitored treatments and a fertility conversation attached — see hCG and best weight loss peptides for men, where whether one provider can manage both sides of that trade-off is the ranking criterion. Everything is indexed on the rankings index.